|
KIAA0895 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62492241884138E-12 |
| Normal-vs-Stage2 |
1.68631775210315E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
4.432000E-01 |
| Stage1-vs-Stage3 |
2.981600E-01 |
| Stage1-vs-Stage4 |
2.246000E-02 |
| Stage2-vs-Stage3 |
1.960150E-01 |
| Stage2-vs-Stage4 |
1.623620E-02 |
| Stage3-vs-Stage4 |
2.458600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.29040000299108E-08 |
| Normal-vs-Asian |
5.21804821573824E-15 |
| Caucasian-vs-AfricanAmerican |
1.855170E-01 |
| Caucasian-vs-Asian |
3.473400E-01 |
| AfricanAmerican-vs-Asian |
6.053000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
7.499600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
2.01019999999108E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.942800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.086400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.941800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.185000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.291600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.788800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.23040000041964E-07 |
| Classical-VS-Follicular |
3.103200E-01 |
| Classical-VS-Other |
6.185600E-01 |
| Classical-VS-Normal |
2.99760216648792E-15 |
| Tall-VS-Follicular |
1.83239999995699E-06 |
| Tall-VS-Other |
1.236180E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
7.177600E-01 |
| Follicular-VS-Normal |
9.70334923522387E-14 |
| Other-VS-Normal |
1.515920E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
3.073600E-01 |
|
|
